News | February 17, 2025
Sanofi updates on extraintestinal pathogenic E. coli vaccine phase 3 clinical study
No safety signals related to the vaccine candidate were identified
No safety signals related to the vaccine candidate were identified
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
EMBLAVEOTM is the first and only monobactam/?-lactamase inhibitor combination antibiotic therapy approved by the USFDA
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
The company remains focused on strengthening its direct retail presence and expanding its reach to more customers across India.
With over 28 years of experience in the pharmaceutical industry, he is a seasoned Techno? Commercial professional and accomplished top management leader
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Rexulti Tablets
QUANTI clinical development program evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and in pediatric and adult patients
He also laid the foundation stone for a state-of-the-art 50-bedded Critical Care Block (CCB)
Prithwish has close to 28 years of experience in a Commercial role
Subscribe To Our Newsletter & Stay Updated
